Furthermore, our observation that patients with TIC referred to any cardiologist were more likely to receive β blockers and ACE inhibitors compared with those who were not referred, even after adjusting for severity of LV dysfunction and hypertension, highlights the importance of facilitating rapid access to cardiology consultation; cardio-oncology clinics are often best able to achieve this. The gene discussed is ACE; the disease is hypertensive disorder.